|
CGC | Canopy Growth Corp |
| Medicinal Chemicals & Botanical Products |
| Book value per $ invested | $ 25.39 |
| Leverage | 33.54% |
| Market Cap | $ 87.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -260.2m |
| Margin | -141.72% |
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.